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IT has recently been shown that homografted Ehrlich ascites carcinoma cells
survive in the face of their host's immunological attack (Hartveit, 1963). The
tumour cells are sensitised but fail to lyse, in the presence of complement, due to
an inhibitor ofimmunological lysis in the ascitic fluid (Hartveit, 1964d). Thus a
form of immunological tolerance is established-allowing the genetically incom-
patible tumour cells to survive, reproduce and kill their host (Hartveit, 1965b).
It has also been shown that the cells ofthe Bergen A4 mouse ascites carcinoma
may be sensitised cells (Hartveit, 1964b). The following study is a demonstration
of the action of cell-free tumour ascitic fluid on such cells in the presence of
complement. As similar results have been obtained repeatedly only specimen
experiments will be reported here.
MATERIAL AND METHODS
Two tumours were used. The BA3 solid mammary carcinoma-i.e. the third
mammary carcinoma to arise spontaneously in a strain A/Sn female mouse
in Bergen, and the BA4 ascites carcinoma, from the same strain, that has been
described previously (Hartveit, 1964a). The BA3 carcinoma is now in its 23rd
transplant generation. The BA4 ascites carcinoma is in its 53rd transplant
generation. When used at a dosage of 0.1 ml. of tumour ascites per mouse it
kills regularly.
Three types of adult mice were used: Inbred strain A/Sn, mice of the closed
colony used at this Institute (Hartveit, 1961), and F1 hybrids (male A/Sn and
female closed colony) between these two strains.
Fresh human serum from blood donor No. 12 and from cancer patient No.
69 were used as a source of complement.
Experimental procedure
Transplantation tests.-This experiment was designed to show that the BA4
ascites carcinoma is a non-specific tumour.
Firstly the solid BA3 carcinoma was ground in a mortar with saline by the
method described previously (Hartveit, 1964a) and then injected subcutaneously
at a dosage of0.1 ml. per mouse into 5 male and 5 female F1 hybrids and 20 male
and 20 female closed colony mice. Fifteen days later the skin of the back was
reflected and tumour and skin removed. These preparations were fixed in forma-
lin and the greatest tumour diameter measured next day. Blocks were then
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taken through this diameter, or in cases where no tumour growth could be seen,
through the known injection site. Slides from these blocks were stained with
haematoxylin and eosin and examined for tumour cells.
Next the BA4 ascites carcinoma was carried for 4 transplant generations
intraperitoneally in female A/Sn mice. Then 0.1 ml. of the tumour ascites from
one of these mice was injected intraperitoneally into each of three male A/Sn, F1
hybrid, and closed colony mice. The tumour grew in all these mice.
IN VITRO tests.-This experiment was designed to show the action of cell-free
BA4 ascitic fluid on BA4 carcinoma cells. The methods used have been described
in detail previously (Hartveit, 1964d).
BA4 tumour ascites was collected from two of the nine day survivors from
the transplantation tests in A/Sn, F1 hybrid and closed colony mice respectively.
One portion of each fluid was used to make a 1 in 20 suspension of tumour cells
in physiological saline. (The tumour cell counts in these were comparable.) The
other portion was centrifuged to obtain the cell-free tumour ascitic fluid. From
these reagents two series of wet preparations were set up. In the first the saline
suspensions of BA4 tumour cells grown in A/Sn, F1 and closed colony mice,
respectively, were set up with saline or cell-free tumour ascites from one of each
ofthe three types of mice in turn, in the presence of serum No. 12. The reagents
were used in the proportions of 1: 1 :1. In the second series tumour cells and
ascites from the second set of mice and serum No. 69 were used.
The wet preparations were kept at 200 C. and examined for tumour cell lysis
every 15 minutes for one hour.
RESULTS
Transplantation tests.-As shown in Table I the BA3 carcinoma grew in 9
out of 10 F1 hybrid mice and in only one out of 40 closed colony mice. Histo-
logically no tumour cells were found in the mice in which no tumour was seen
macroscopically.
TABLE I.-Greatest Tnmour Diameter in 5 Male and 5 Female F1 Hybrids and
20 Male and 20 Female Closed Colony Mice 15 Days After the Subcutaneous
Injection of BA3 Carcinoma Cells.
Number of mice with tumour
Type of diameter (cm.)
mouse ,
I&- OverO 1 0-01 5 Under0 5 Nil
F1 hybrid . 5 0 0 0
(A/Sn x CC*)Y . 4 0 0 1
Closed colony T . 0 0 1 19
0 0 0 20
* see text.
As mentioned above the BA4 carcinoma grew in all three types of mice.
IN VITRO tests.-Table II shows that the BA4 tumour cells grown in A/Sn, F1
hybrid and closed colony mice all behaved in the same way. Tumour cell lysis
occurred only in the combination-cells, saline, serum (i.e. complement). Serum
No. 12 was more stronglylytic than serum No. 69. In both series the combination
,-cells, saline, saline-gave no lysis. In the other three combinations of-
cells, ascitic fluid, serum-lysis failed to occur.
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TABLE I1.-The Inhibitory Effect of Cell-free Ascitic Fluid from BA4 Mouse
Ascites Carcinoma Grown in Strain A/Sn, Closed Colony and F1 Hybrids
of These Two Strains (A, CC and F1 Ascites, Respectively), on the Oncolytic
Action of Blood Donor Serum 12 and Cancer Patient Serum 69 on a 1 in 20
Saline Suspension of Cells from the Same Tumour, Grown in the Same 3
Strains of Mice (A, CC and F1 Cells, Respectively), with Saline Controls,
Related to Time (Minutes) at 200 C.
Degree of oncolysis*
with serum 12t with serum 69T
mn. mmin.
Reagents A
1:1:1 0 15 30 45 60 0 15 30 45 60
A cells A ascites serum . 00 0 0 0 0 0 0 0 0
,, F ,, ,, .0 0 0 0 0 00 0 0 0
,,CC ,, ,, .0 0 0 0 0 0 0 0 0
saline ,, . + +±++ +±+ + + + +
,, saline .0 0 0 0 0 0 0 0 0 0
F1 cells A ascites serum .0 0 0 0 0 0 0 0 0 0
F ,, ,, .0 0 0 0 0 0 0 0 0
,, CC ,, ,, . 0 0 0 0 0 0 0
,, saline ,, . + ++ ++ ++ 0 0 + + +
,, ,, saline .0 0 0 0 0 0 0 0 0 0
CC cells A ascites serum . 0 0 0 0 0 0 0 0 0 0
,, F 9,, ,, .0 00 0 0 000 0 0
,, CC ,, ,, .0 0 0 0 0 0 0 0 0
saline .+ + ++ ++ ++ 0 + + + +
saline .0 0 0 0 0 0 0 0 0 0
* 0 no lytic cells.
+ up to 80 per cent lytic cells.
++ over 80 per cent lytic cells.
t using first series of cells and ascites.
using second series of cells and ascites.
DISCUSSION
The transplantation tests show that the BA3 carcinoma is a strain specific
tumour, as it grew in F1 hybrid mice ofits strain oforigin but failed to grow in all
but one of the unrelated closed colony mice. The BA4 carcinoma, on the other
hand, grew in all three types of mice used. The latter can therefore be regarded
as a non-specific tumour, as it can grow in mice that have been shown to be
genetically incompatible with a strain specific A/Sn tumour.
This finding makes it possible to grow the BA4 carcinoma in both genetically
compatible and incompatible mice, and to compare the growth. In the present
case the tumour was transplanted in two compatible systems, i.e. mice of the
strain of origin and F1 hybrids of this strain, and in incompatible closed colony
mice. It has been shown previously (Hartveit, 1964b) that the tumour cells
grown in one ofthese compatible systems, i.e. F1 mice, are sensitised by their host,
as they lyse in the presence of complement in vitro. This observation was re-
peatedhere asthe combination oftumour cells grownin F1 mice-saline and serum
-gave lysis. Tumour cells grown in the other compatible system, A/Sn mice,
also gave lysis. Thus these cells also have been sensitised. Similarly the tumour
cells grown in the closed colony mice also lysed. Here we have a system com-
parable with that ofthe Ehrlich ascites carcinoma in the closed colony (Hartveit,
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1965a). So the finding that such homografted cells become sensitised is no
surprise.
Now it has recently been shown that the cell-free ascitic fluid from the Ehrlich
ascites carcinoma can prevent the lysis of sensitised Ehrlich cells (Hartveit,
1964d). Indeed it is this mechanism that permits the progressive growth of this
tumour homograft as it allows a form ofimmunological tolerance to be established.
In view of this finding it was tempting to postulate that a similar mechanism
might explain the non-specific growth ofthe BA4 ascites carcinoma. The present
experiment shows that this is so. Some factor or factors in the ascitic fluid
prevent immunological lysis in vitro. As the only active factor added to the
system in vitro is complement (Hartveit, 1965a), and as complement is present
in these host mice in vivo (Hartveit, 1964c), it is reasonable to postulate that
the inhibitory effect ofthe ascitic fluid explains tumour growth in this genetically
incompatible system in vivo also. Thus these findings with homografted BA4
are in accordance with the previous findings with homografted Ehrlich ascites
carcinoma.
But the tumour cells were also transplanted in two genetically compatible
systems-and in each case gave similar results. In both cases the tumour cells
lysed in the presence of complement-except when ascitic fluid was added to the
system. In addition the ascitic fluids were interchangeable. Thus the inhibiting
factor(s) is not specific to the cells grown in the type of mouse in which it is pro-
duced. Whether it is specific to the type of tumour cells in response to which
it was produced remains to be seen.
The very existance of such an inhibitory mechanism that permits the growth
of tumour cells raises many questions. When this mechanism was first described
in connection with the Ehrlich ascites carcinoma it merely explained the growth
of a tumour homograft-not of a tumour as such. In the present case, with BA4
carcinoma growing in genetically compatible systems, this mechanism explains
the growth of a tumour. The tumour cells have been sensitised-that is to say
the genetically compatible host has reacted immunologically against some factor
in the tumour (i.e. a tumour specific antigen) and produced an antibody to what
would otherwise have been regarded as " self" tissue. The host has thus
produced an antibody to what could be described as " changed-self " and this
change in self tissue is associated with the characteristics we describe as malig-
nancy. But at the same time the tumour tissue survives as the host's immuno-
logical defence is negated by the state of tolerance induced by the ascitic fluid.
Thus these tumour cells, like the homografted cells, survive, reproduce and kill
their host in spite of its immune response.
This finding gives ample scope for speculation as to the possible presence of
such a system oftolerance to other antibodies produced in response to " changed-
self ", both in the field of tumour immunity and possibly that of the " auto-
immune" diseases.
SUMMARY
The Bergen A4 ascites carcinoma is shown to be a tumour of non-specific type,
like the Ehrlich ascites carcinoma. The explanation of its growth in genetically
incompatible mice is similar to that of Ehrllch ascites carcinoma in such mice,
the inhibitory effect of the ascitic fluid preventing the immunological lysis of the
tumour cells that-are sensitised by the host. In addition a similar mechanism
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of immunological tolerance is shown to apply to growth of the BA4 carcinoma
in genetically compatible mice, in which the tumour cells have been sensitised
by virtue of the presence in them of an antigen that is lacking in the normal
tissues of their host.
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